China will take steps to make it easier for medicines produced by foreign-invested pharmaceutical companies to enter retail pharmacy channels, a Commerce Ministry official said on June 22.
Speaking at a State Council Information Office briefing, WANG Ya, an official with the Ministry of Commerce, said the newly released foreign investment action plan also includes measures to study cross-border segmented manufacturing of chemical drugs, expand pilot programs for biotechnology and wholly foreign-owned hospitals, and encourage insurers to cover more innovative drugs and medical devices.
The plan is aimed at supporting greater foreign participation in China's pharmaceutical industry, Wang said.
